ClinicalTrials.Veeva

Menu

Evaluation of the GORE® C3 Delivery System Module

W.L. Gore & Associates logo

W.L. Gore & Associates

Status

Completed

Conditions

Aortic Aneurysm, Abdominal

Treatments

Device: Stent graft (EXCLUDER)

Study type

Observational

Funder types

Industry

Identifiers

NCT01398332
GRT 10-12

Details and patient eligibility

About

This is an observational Registry designed to obtain early data on the use of the GORE® EXCLUDER® AAA Endoprosthesis with C3 Delivery System.

Full description

This is a retrospective and prospective observational cohort Registry designed to obtain data on the use of the GORE® EXCLUDER® AAA Endoprosthesis with C3 Delivery System. Patient and device performance outcomes will be collected during treatment and throughout all post-treatment visits, including follow-up extending up to 10 years.

Enrollment

399 patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

  1. Minimum age required by local regulations (as applicable)
  2. Indication for aortic endovascular stent graft repair as determined by the treating physician (refer to current Instructions for Use of the GORE® EXCLUDER® AAA Endoprosthesis with C3 Delivery System)

Trial design

399 participants in 1 patient group

Aortic pathologies
Description:
Indication for aortic endovascular stent graft repair
Treatment:
Device: Stent graft (EXCLUDER)

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems